OAM
UTHR icon

Origin Asset Management’s United Therapeutics UTHR Stock Holding History

Origin Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,030
Closed -$222K – 50
2021
Q4 		$222K Sell
1,030
-1,539
-60% -$302K 0.05% 40
2021
Q3 		$474K Sell
2,569
-16,191
-86% -$3.19M 0.11% 8
2021
Q2 		$3.37M Buy
18,760
+1,135
+6% +$216K 0.38% 22
2021
Q1 		$2.95M Sell
17,625
-600
-3% -$100K 0.3% 28
2020
Q4 		$2.77M Buy
+18,225
New +$2.39M 0.26% 32
2017
Q2 		– Sell
-155,620
Closed -$21.1M – 130
2017
Q1 		$21.1M Buy
155,620
+4,369
+3% +$662K 1.31% 28
2016
Q4 		$21.7M Buy
151,251
+88,650
+142% +$11.3M 1.43% 24
2016
Q3 		$7.39M Sell
62,601
-3,600
-5% -$433K 0.47% 72
2016
Q2 		$7.01M Buy
66,201
+700
+1% +$78.1K 0.47% 76
2016
Q1 		$7.3M Buy
65,501
+10,064
+18% +$1.27M 0.51% 74
2015
Q4 		$8.68M Sell
55,437
-1,325
-2% -$193K 0.7% 47
2015
Q3 		$7.45M Sell
56,762
-58,597
-51% -$9.4M 0.62% 54
2015
Q2 		$20.1M Sell
115,359
-14,606
-11% -$2.63M 1.46% 23
2015
Q1 		$22.4M Sell
129,965
-2,135
-2% -$325K 1.65% 19
2014
Q4 		$17.1M Sell
132,100
-3,889
-3% -$501K 1.3% 31
2014
Q3 		$17.5M Sell
135,989
-62,143
-31% -$6.41M 1.13% 38
2014
Q2 		$17.5M Sell
198,132
-6,232
-3% -$599K 1.13% 36
2014
Q1 		$19.2M Sell
204,364
-13,400
-6% -$1.37M 1.28% 34
2013
Q4 		$24.6M Sell
217,764
-67,899
-24% -$6.12M 1.65% 22
2013
Q3 		$22.5M Sell
285,663
-9,519
-3% -$696K 1.68% 24
2013
Q2 		$19.4M Buy
+295,182
New +$19M 1.69% 23

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Origin Asset Management's UTHR Position: Q1 2022 in Review

Origin Asset Management sold out of United Therapeutics (UTHR) in Q1 2022, closing a stake of 1,030 shares — an estimated $222K sold.

Origin Asset Management first reported a position in UTHR in Q2 2013 and held it in 21 quarters. The position peaked at $24.6M in Q4 2013. 427 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.

  • Origin Asset Management reported no remaining United Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Origin Asset Management sold 1,030 United Therapeutics shares in Q1 2022, an estimated $222K.
  • Origin Asset Management first reported a position in United Therapeutics in Q2 2013 and held it in 21 quarters.
  • Origin Asset Management's United Therapeutics position peaked at $24.6M in Q4 2013.
  • 427 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.

Based on Origin Asset Management's 13F filing for Q1 2022, filed 24 May 2022.